Step 1 topics → Microbiology → Aspergillus

Aspergillus

USMLE Step 1 trap: Confuses the host context for invasive aspergillosis with that of ABPA. Invasive aspergillosis occurs in neutropenic or severely immunocompromised hosts; ABPA (allergic form) occurs in asthmatics and CF patients.

Aspergillus is a mold that causes three distinct disease forms, each tied to a specific host context — and that host-disease pairing is exactly what USMLE Step 1 tests. The most common error is conflating the forms: invasive aspergillosis requires profound immunosuppression (neutropenia, transplant) and is treated with voriconazole, while ABPA is a hypersensitivity reaction in asthmatics or CF patients treated with corticosteroids — applying voriconazole to ABPA gets you the wrong answer, not a partial credit. The histology anchor is septate hyphae branching at 45° acute angles — the key discriminator from Mucor/Rhizopus, which have non-septate hyphae at wide 90° angles. Get the host context and morphology right, and the treatment follows directly.

The histology is a high-yield anchor: Aspergillus has septate hyphae that branch at 45° acute angles. That detail shows up in both direct identification questions and as a discriminator from Mucor/Rhizopus, which have non-septate hyphae branching at wide 90° angles. For diagnosis, the galactomannan antigen assay (serum or BAL) is key for invasive disease — Step 1 has moved toward testing this over culture. ABPA has its own diagnostic fingerprint: elevated IgE, eosinophilia, positive Aspergillus skin test, and central bronchiectasis on imaging.

What makes Aspergillus tricky is that students collapse all three forms into one and apply treatments or host contexts interchangeably. Voriconazole gets misapplied to ABPA. Invasive aspergillosis gets attributed to asthmatics. These aren't random mistakes — they come from not having a locked-in mental model for each form. Build that model first, and the rest follows.

From real student decks
76%have cards covering this topic
65%have mature cards

Common misconceptions

Common mistake
Wrong: Invasive aspergillosis occurs in atopic/asthmatic patients rather than neutropenic ones.
Right: Invasive aspergillosis occurs in neutropenic or severely immunocompromised hosts; ABPA (allergic form) occurs in asthmatics and CF patients.
Invasive aspergillosis requires a severely blunted innate immune response — specifically neutropenia or profound immunosuppression (e.g., post-transplant, prolonged steroids). Neutrophils are the primary defense against hyphal invasion. ABPA, by contrast, is a hypersensitivity (Th2-driven, IgE-mediated) reaction in patients with hyperreactive airways — asthmatics and CF patients — who are not immunocompromised in the classical sense. When the vignette mentions an asthmatic with wheezing, eosinophilia, and elevated IgE, that's ABPA territory, not invasive disease.
Common mistake
Wrong: Aspergillus hyphae branch at wide (90°) angles, like Mucor.
Right: Aspergillus has septate hyphae branching at 45° acute angles, while Mucor has non-septate hyphae branching at wide 90° angles.
The branching angle is one of the most tested histologic discriminators in fungal microbiology. Aspergillus produces septate hyphae that branch at acute 45° angles — think of a sharp V-shape. Mucor and Rhizopus produce non-septate (coenocytic) hyphae that branch at wide 90° right angles — think of a T or right angle. Both can cause invasive pulmonary disease in immunocompromised hosts, so the hyphae appearance on GMS or H&E stain is often your only discriminator in a vignette.
Common mistake
Wrong: Voriconazole is the treatment for ABPA (allergic bronchopulmonary aspergillosis).
Right: ABPA is treated with corticosteroids (and sometimes itraconazole), while invasive aspergillosis is treated with voriconazole.
The treatment logic follows the pathophysiology. ABPA is an allergic/hypersensitivity disease — the immune system is overreacting, so you dampen it with corticosteroids. Antifungals (itraconazole) may be added to reduce fungal burden and allow steroid tapering, but voriconazole is not indicated. Voriconazole is reserved for invasive aspergillosis, where the fungus is actively destroying tissue in an immunocompromised host and you need a potent mold-active azole. Applying voriconazole to ABPA conflates two completely different pathophysiologic scenarios.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a patient's immune status or underlying condition (e.g., neutropenia, asthma, prior TB with cavity), identify which of the three Aspergillus disease forms they are at risk for and what the expected clinical presentation is.
  2. Identify Aspergillus on histology or describe its microscopic appearance — specifically septate hyphae branching at 45° — and distinguish it from Mucor/Rhizopus based on septation and branching angle.
  3. Select the correct treatment for a given Aspergillus presentation: voriconazole for invasive aspergillosis versus corticosteroids (with or without itraconazole) for ABPA, and recognize that aspergilloma may require surgical resection.

Can you avoid these mistakes?

A 35-year-old man with a history of pulmonary tuberculosis presents with hemoptysis. Chest CT shows a cavity in the right upper lobe with a mobile mass inside and an 'air crescent sign.' What is the diagnosis, what organism is responsible, and what is the management?
On bronchoscopy biopsy from a neutropenic patient with fever unresponsive to antibiotics, you see septate hyphae branching at acute angles invading blood vessel walls. What organism does this, how does its morphology differ from Mucor on histology, and what do you treat with?
A 22-year-old with cystic fibrosis has worsening wheezing, a serum IgE of 1800 IU/mL, peripheral eosinophilia, and central bronchiectasis on CT. Aspergillus skin prick test is positive. What is the diagnosis, and what is the first-line treatment?
You're given two histology images: one shows wide-angle, non-septate hyphae; the other shows narrow, septate hyphae with 45° branching. Which corresponds to Aspergillus, which to Mucor, and which patient scenario (neutropenic with uncontrolled diabetes in DKA vs. neutropenic post-chemo) fits each organism?

Related topics

Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →